Envoy Medical draws $2.5M from GAT Funding note, issues warrant for 250K shares

Envoy Medical, Inc.

Drew $2.5M under existing note from GAT Funding, aggregate principal now $10M.
Issued warrant to GAT for 250,000 shares at $2.25 exercise price, expiring Feb 27, 2026.
GAT is controlled by board member Glen Taylor, a related-party transaction.
Warrant issued as commitment fee for the draw; shares exempt from registration under Rule 506.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.